W.R. Berkley (NYSE:WRB – Get Free Report) had its price objective lowered by stock analysts at Truist Financial from $80.00 to $78.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the insurance provider’s stock. Truist Financial’s target price indicates a potential upside of 13.88% from the stock’s current price.
Other equities analysts have also recently issued reports about the stock. Barclays decreased their price objective on shares of W.R. Berkley from $64.00 to $62.00 and set an “underweight” rating for the company in a research report on Wednesday, April 8th. Argus decreased their price objective on shares of W.R. Berkley from $82.00 to $76.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. Mizuho decreased their price objective on shares of W.R. Berkley from $69.00 to $67.00 and set a “neutral” rating for the company in a research report on Tuesday, January 27th. The Goldman Sachs Group reissued a “neutral” rating and issued a $73.00 price objective on shares of W.R. Berkley in a research report on Wednesday, January 7th. Finally, UBS Group reduced their price target on shares of W.R. Berkley from $71.00 to $69.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 8th. Three equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, W.R. Berkley currently has an average rating of “Hold” and an average price target of $68.88.
Check Out Our Latest Analysis on WRB
W.R. Berkley Stock Performance
W.R. Berkley (NYSE:WRB – Get Free Report) last posted its quarterly earnings data on Tuesday, April 21st. The insurance provider reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.13 by $0.17. The company had revenue of $3.69 billion during the quarter, compared to analysts’ expectations of $3.18 billion. W.R. Berkley had a net margin of 12.64% and a return on equity of 18.99%. The firm’s revenue for the quarter was up 1.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.01 EPS. On average, research analysts expect that W.R. Berkley will post 4.55 earnings per share for the current fiscal year.
Insider Activity at W.R. Berkley
In related news, major shareholder Sumitomo Insurance Co L. Mitsui purchased 370,000 shares of W.R. Berkley stock in a transaction dated Monday, January 26th. The shares were acquired at an average price of $67.07 per share, with a total value of $24,815,900.00. Following the completion of the transaction, the insider owned 54,959,504 shares of the company’s stock, valued at approximately $3,686,133,933.28. This trade represents a 0.68% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders have bought a total of 4,150,946 shares of company stock worth $289,060,858 over the last quarter. Company insiders own 23.30% of the company’s stock.
Hedge Funds Weigh In On W.R. Berkley
Large investors have recently modified their holdings of the stock. Johnson Financial Group Inc. increased its stake in shares of W.R. Berkley by 22.3% during the third quarter. Johnson Financial Group Inc. now owns 756 shares of the insurance provider’s stock valued at $58,000 after acquiring an additional 138 shares during the period. Maridea Wealth Management LLC increased its stake in shares of W.R. Berkley by 2.0% during the third quarter. Maridea Wealth Management LLC now owns 7,180 shares of the insurance provider’s stock valued at $528,000 after acquiring an additional 141 shares during the period. Inspire Advisors LLC boosted its holdings in W.R. Berkley by 1.0% during the fourth quarter. Inspire Advisors LLC now owns 14,364 shares of the insurance provider’s stock worth $1,007,000 after buying an additional 144 shares in the last quarter. Physician Wealth Advisors Inc. boosted its holdings in W.R. Berkley by 40.2% during the third quarter. Physician Wealth Advisors Inc. now owns 523 shares of the insurance provider’s stock worth $40,000 after buying an additional 150 shares in the last quarter. Finally, Valeo Financial Advisors LLC boosted its holdings in W.R. Berkley by 3.3% during the third quarter. Valeo Financial Advisors LLC now owns 4,788 shares of the insurance provider’s stock worth $367,000 after buying an additional 151 shares in the last quarter. Institutional investors own 68.82% of the company’s stock.
W.R. Berkley News Roundup
Here are the key news stories impacting W.R. Berkley this week:
- Positive Sentiment: Q1 beat and strategic shift — WRB posted an EPS beat and management signaled a shift toward growth over rate, with quarterly ROE at ~21.2%, a key profitability metric that supports higher returns and investor confidence. W. R. Berkley signals shift toward growth vs. rate as Q1 2026 ROE reaches 21.2%
- Positive Sentiment: Record income and strong call highlights — Management reiterated capital-return priorities and Q1 produced record net income, items that support shareholder returns and valuation. W. R. Berkley Tops Q1 With Record Income
- Positive Sentiment: Value case highlighted — Analysts at Zacks point to WRB’s attractive valuation metrics and style scores, which may draw value-focused investors after the report. Here’s Why W.R. Berkley (WRB) is a Strong Value Stock
- Neutral Sentiment: Mixed operating details — While investment income and underwriting results helped EPS, premiums/revenue were slightly below some estimates, making the quarter mixed beneath the headline beat. W.R. Berkley’s Q1 Earnings Surpass Estimates, Revenues Miss
- Neutral Sentiment: Market dynamics noted — Coverage pieces highlight rising competition as the underwriting cycle shifts, which could pressure pricing going forward even as management focuses on returns. WRB Q1 deep dive: Competition rises as cycle shifts, capital returns remain a focus
- Neutral Sentiment: Full call/transcript available — Analysts and investors are parsing the transcript for reserve development, pricing comments and reinsurance/program details that will drive forward expectations. W. R. Berkley Corporation (WRB) Q1 2026 Earnings Call Transcript
- Negative Sentiment: Analyst price-target cuts/downgrade tone — Wells Fargo lowered its target to $64 (equal-weight), and other firms adjusted targets (Barclays lifted its target slightly but kept an underweight stance; Truist trimmed its target while keeping a buy). These moves can cap near-term upside and contributed to mixed market reaction. Analyst price target and rating notes (Benzinga)
About W.R. Berkley
W. R. Berkley Corporation (NYSE: WRB) is a publicly traded insurance holding company that underwrites and sells commercial property and casualty insurance, specialty insurance products, and reinsurance. Headquartered in Greenwich, Connecticut, the company operates a portfolio of underwriting businesses that focus on niche and specialty commercial risks, offering coverage tailored to industries such as transportation, construction, professional services and other commercial lines.
The company’s product mix includes primary and excess casualty, property, professional liability, environmental and other specialty lines, together with treaty and facultative reinsurance solutions.
Read More
Receive News & Ratings for W.R. Berkley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for W.R. Berkley and related companies with MarketBeat.com's FREE daily email newsletter.
